Table 1.
Cancer Therapy | Risky Health Behaviors* (%) |
Medical Care† (%) |
|||||
---|---|---|---|---|---|---|---|
Current Smoker | Risky Drinking | Physically Inactive | No Medical Care | General Medical Care | General Survivor-Focused Care | Risk-Based Survivor-Focused Care | |
Total cohort | 14.3 | 14.5 | 23.9 | 11.2 | 57.3 | 13.7 | 17.8 |
Chest radiation therapy | |||||||
Yes | 13.0 | 14.0 | 20.8 | 7.9 | 49.3 | 14.7 | 28.0 |
No | 14.8 | 14.8 | 24.9 | 12.0 | 59.4 | 13.3 | 15.3 |
Anthracyclines ≥ 300 mg/m2 | |||||||
Yes | 12.1 | 14.1 | 23.0 | 11.3 | 55.4 | 13.1 | 20.2 |
No | 14.7 | 14.7 | 24.1 | 11.1 | 57.8 | 13.7 | 17.3 |
Pulmonary toxic therapy‡ | |||||||
Yes | 11.6 | 12.9 | 25.8 | 8.4 | 51.9 | 15.5 | 24.1 |
No | 14.7 | 14.9 | 23.6 | 11.5 | 58.0 | 13.4 | 17.0 |
Alkylating agent therapy | |||||||
Yes | 12.4 | 14.4 | 22.9 | 10.6 | 52.2 | 14.6 | 22.5 |
No | 15.0 | 14.9 | 24.5 | 11.5 | 59.5 | 13.1 | 15.9 |
Includes only survivors 18 years or older who responded; current smoker and physically inactive sample size is 6,244 participants who responded to the 2003 Childhood Cancer Survivor Study (CCSS) survey; risky drinking sample size is 8,988 participants who responded to the baseline CCSS survey.
Includes survivors of any age who completed the 2003 CCSS survey; sample size is 8,522 participants.
Pulmonary toxic therapies include any of the following: bleomycin, busulfan, carmustine, lomustine.